Skip to main content
SpringerLink
Log in

Crunch time for peer review in lawsuit

  • News
  • Published:

From Nature

View current issue Submit your manuscript

Ruling imminent on Pfizer's challenge to journal confidentiality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Meredith Wadman
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Cardiovascular medicine

Pharmacology

Related external links

The New England Journal of Medicine

Pfizer

Science Editorial, 22 February 2008

US District court, Massachusetts

Clinicaltrials.gov description of ongoing Pfizer-sponsored Celebrex/naproxen/ibuprofen trial

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wadman, M. Crunch time for peer review in lawsuit. Nature 452, 6–7 (2008). https://doi.org/10.1038/452006a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/452006a

  • Springer Nature Limited

Search

Navigation